Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: Final results of a pilot phase II study

Massimo Federico, Stefano Luminari, Cinzia Pellegrini, Francesco Merli, Emanuela Anna Pesce, Stephane Chauvie, Letizia Gandolfi, Isabella Capodanno, Massimiliano Salati, Lisa Argnani, Pier Luigi Zinzani

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e139-e141
Number of pages3
Issue number4
Publication statusPublished - Mar 31 2016


  • ABVD
  • Brentuximab vedotin
  • Early
  • Hodgkin lymphoma
  • Intermediate
  • Radiotherapy
  • Toxicity

ASJC Scopus subject areas

  • Hematology

Cite this